Scientific article
Letter
English

Reevaluating the safety of shortened antibiotic treatment : a critical evaluation of the EUROBACT-2 study. Authors' reply

Published inIntensive care medicine, vol. 51, no. 6, p. 1198-1199
Publication date2025-06
First online date2025-05-05
Abstract

Reply to : Pruc M, Maslyk M, Krupa A, Szarpak L. Reevaluating the safety of shortened antibiotic treatment: a critical evaluation of the EUROBACT-2 study. Intensive Care Med. 2025 Jun;51(6):1196-1197. doi: 10.1007/s00134-025-07919-9. Epub 2025 Apr 29. PMID: 40298975. Which was a comment on : Gajdos L, Buetti N, Tabah A, Ruckly S, Akova M, Sjöval F, Arvanti K, de Waele J, Bracht H, Barbier F, Timsit JF; EUROBACT-2 Study Group, the European Society of Intensive Care Medicine (ESICM), the European Society of Clinical Microbiology, the Infectious Diseases (ESCMID) Study Group for Infections in Critically Ill Patients (ESGCIP) and the OUTCOMEREA Network. Shortening antibiotic therapy duration for hospital-acquired bloodstream infections in critically ill patients: a causal inference model from the international EUROBACT-2 database. Intensive Care Med. 2025 Mar;51(3):518-528. doi: 10.1007/s00134-025-07857-6. Epub 2025 Apr 7. PMID: 40192823. https://archive-ouverte.unige.ch/unige:185050

Keywords
  • EUROBACT
  • Antibiotic treatment
Citation (ISO format)
GAJDOS, Lena et al. Reevaluating the safety of shortened antibiotic treatment : a critical evaluation of the EUROBACT-2 study. Authors” reply. In: Intensive care medicine, 2025, vol. 51, n° 6, p. 1198–1199. doi: 10.1007/s00134-025-07927-9
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN0342-4642
28views
0downloads

Technical informations

Creation17/06/2025 12:14:26
First validation01/07/2025 10:00:26
Update01/07/2025 10:00:26
Status update01/07/2025 10:00:26
Last indexation01/07/2025 10:00:27
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack